You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

androgen independent

Showing 1 - 25 of 4,701
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)

Completed
Has Results
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 16, 2022

Prostate Cancer Trial in Argentina, United States (Sagopilone (ZK 219477) + prednisone)

Completed
  • Prostate Cancer
  • Sagopilone (ZK 219477) + prednisone
  • Fountain Valley, California
  • +16 more
Apr 6, 2021

Prostate Cancer Trial in Ann Arbor, Seattle (Aplidin (plitidepsin))

Terminated
Has Results
  • Prostate Cancer
  • Aplidin (plitidepsin)
  • Ann Arbor, Michigan
  • +1 more
Nov 16, 2020

Prostate Cancer Trial in Louisville (Taxotere, Doxil)

Completed
Has Results
  • Prostate Cancer
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 29, 2019

Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker

Completed
  • Recurrent Prostate Carcinoma
  • Stage IV Prostate Cancer AJCC v7
  • Ipilimumab
  • +3 more
  • San Francisco, California
    UCSF Medical Center-Mount Zion
Jul 29, 2020

Prostatic Tumors Trial run by the NCI (PROSTVAC-V/TRICOM, PROSTVAC-F/TRICOM, MDX-010)

Completed
  • Prostatic Neoplasms
  • PROSTVAC-V/TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

Prostatic Tumors Trial run by the NCI (Ketaconazole, Docetaxel)

Completed
  • Prostatic Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 20, 2019

Prostate Cancer, Metastases Trial (Romidepsin)

Completed
  • Prostate Cancer
  • Metastases
  • (no location specified)
Nov 14, 2019

Metastatic Androgen Independent Prostate Cancer Trial in Canada, United States (APC8015F)

Completed
Has Results
  • Metastatic Androgen Independent Prostate Cancer
  • APC8015F
  • Los Angeles, California
  • +57 more
Sep 3, 2021

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Prostate Cancer Trial in United States (perillyl alcohol)

Completed
  • Prostate Cancer
  • perillyl alcohol
  • Freeport, Illinois
  • +7 more
Dec 12, 2019

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Prostate Cancer Trial in Toronto (Cytarabine)

Completed
  • Prostate Cancer
  • Toronto, Ontario, Canada
    University Health Network
Feb 13, 2019

Tumor Recurrence Following Radiotherapy

Recruiting
  • Prostate Cancer
    • Rochester, Minnesota
      Mayo Clinic
    Jan 20, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 23, 2023

    Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))

    Active, not recruiting
    • Metastatic Hormone Sensitive Prostate Cancer
    • Beijing, China
    • +29 more
    Jan 7, 2023

    Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer Trial in United States (VERU-111,

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Androgen Resistant Prostatic Cancer
    • Anchorage, Alaska
    • +43 more
    Jan 3, 2023

    Androgen Metabolism, Metabolic Disease and Skeletal Muscle

    Not yet recruiting
    • Hypogonadism, Male
    • +10 more
    • Dublin 9, Ireland
      Beaumont Hospital
    Mar 16, 2023

    Prostate Cancer Trial in Park Ridge (GM CSF)

    Completed
    Has Results
    • Prostate Cancer
    • GM CSF
    • Park Ridge, Illinois
      Oncology Specialists, SC
    Mar 19, 2019

    Metastatic Hormone-Sensitive Prostate Cancer Trial in China (biological, drug, procedure, other)

    Active, not recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer
    • Pembrolizumab
    • +3 more
    • Beijing, Beijing, China
    • +23 more
    Sep 30, 2022

    Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)

    Not yet recruiting
    • Oligometastatic Prostate Cancer (OMPC)
    • (no location specified)
    Jul 3, 2023

    Metastatic Hormone Sensitive Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

    Active, not recruiting
    Has Results
    • Metastatic Hormone Sensitive Prostate Cancer
    • Homewood, Alabama
    • +202 more
    Jul 29, 2022

    Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

    Recruiting
    • Metastatic Breast Cancer
    • Anchorage, Alaska
    • +58 more
    Jan 6, 2023